Second, whereas Glasgow and CRP-based prognostic assessment systems have been found to be helpful and important indicators of overall survival for pancreatic cancer, CRP wasn’t routinely evaluated in our patient population. This evidence concerns the gene CRP and familial pancreatic carcinoma.